Back
United Therapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
55
UTHR
United Therapeutics
Last Price:
352.83
Seasonality Move:
2.3%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing slight buying pressure.
United Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 345.42 | Buy |
| 20-day SMA: | 349.18 | Buy |
| 50-day SMA: | 338.34 | Buy |
| 200-day SMA: | 270.74 | Buy |
| 8-day EMA: | 347.53 | Buy |
| 20-day EMA: | 345.88 | Buy |
| 50-day EMA: | 335.45 | Buy |
| 200-day EMA: | 287.15 | Buy |
United Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.75 | Buy |
| Relative Strength Index (14 RSI): | 58.11 | Buy |
| Chaikin Money Flow: | 139370 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (340 - 355.9) | Buy |
| Bollinger Bands (100): | (280.1 - 344.26) | Buy |
United Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 353.01 while UTHR 8-day simple moving average is 345.42, which is a Buy signal.
- The stock price of UTHR is 353.01 while United Therapeutics 20-day SMA is 349.18, which makes it a Buy.
- United Therapeutics 50-day simple moving average is 338.34 while UTHR share price is 353.01, making it a Buy technically.
- UTHR stock price is 353.01 and United Therapeutics 200-day simple moving average is 270.74, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a Buy
The current United Therapeutics [UTHR] share price is $353.01. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
15.71B
Price in USD:
353.01
Share Volume:
352.53K
United Therapeutics 52-Week Range
52-Week High:
366.08
52-Week Low:
208.62
Buy
55
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?
The United Therapeutics stock price is 353.01 USD today. -
Will UTHR stock go up or go down?
United Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is United Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 353.01 while UTHR 8-day exponential moving average is 347.53, which is a Buy signal.
- The stock price of UTHR is 353.01 while United Therapeutics 20-day EMA is 345.88, which makes it a Buy.
- United Therapeutics 50-day exponential moving average is 335.45 while UTHR share price is 353.01, making it a Buy technically.
- UTHR stock price is 353.01 and United Therapeutics 200-day simple moving average is 287.15, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.87 per share, and an increase next year of $1.42 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
- UTHR Moving Average Covergence Divergence (MACD) indicator is 2.75, suggesting United Therapeutics is a Buy
- United Therapeutics Relative Strength Index (RSI) is 58.11, which suggest United Therapeutics is overbought
- The Bollinger Bands (25) for United Therapeutics is (340 - 355.9), which suggest United Therapeutics is a Buy
- The Bollinger Bands (100) for United Therapeutics is (280.1 - 344.26), which suggest United Therapeutics is a Buy
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.